RG2833 (RGFP109)
98%
- Product Code: 102305
CAS:
1215493-56-3
| Molecular Weight: | 339.43 g./mol | Molecular Formula: | C₂₀H₂₅N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
RG2833 (RGFP109) is primarily researched for its potential therapeutic applications in neurological and psychiatric disorders. It functions as a histone deacetylase (HDAC) inhibitor, specifically targeting HDAC1 and HDAC3, which are involved in gene expression regulation. This mechanism makes it a candidate for treating conditions like Huntington's disease, where it has shown promise in preclinical studies by improving motor function and reducing neurodegeneration. Additionally, it is being explored for its potential in addressing cognitive impairments and mood disorders, as HDAC inhibition can enhance synaptic plasticity and memory formation. Research is ongoing to evaluate its efficacy and safety in clinical settings.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $154.98 |
+
-
|
| 0.025 | 10-20 days | $432.07 |
+
-
|
| 0.100 | 10-20 days | $995.64 |
+
-
|
RG2833 (RGFP109)
RG2833 (RGFP109) is primarily researched for its potential therapeutic applications in neurological and psychiatric disorders. It functions as a histone deacetylase (HDAC) inhibitor, specifically targeting HDAC1 and HDAC3, which are involved in gene expression regulation. This mechanism makes it a candidate for treating conditions like Huntington's disease, where it has shown promise in preclinical studies by improving motor function and reducing neurodegeneration. Additionally, it is being explored for its potential in addressing cognitive impairments and mood disorders, as HDAC inhibition can enhance synaptic plasticity and memory formation. Research is ongoing to evaluate its efficacy and safety in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :